Role of kinases in HTLV-I transformation

Journal of Investigative Medicine

Volumn 44, Issue 4, 1996, Pages 113-121

  Xu, Xiao ^a   Heidenreich, Olaf ^a   Nerenberg, Michael ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JAK3 PROTEIN, HUMAN; JAK3 PROTEIN, MOUSE; JANUS KINASE 3; PROTEIN KINASE; PROTEIN TYROSINE KINASE;

ANIMAL; APOPTOSIS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; MOUSE; PHYSIOLOGY; REGULATOR GENE; REVIEW; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; T LYMPHOCYTE; VIROLOGY; VIRUS CELL TRANSFORMATION;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION REGULATION, VIRAL; GENES, PX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JANUS KINASE 3; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MICE; PROTEIN KINASES; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 0030117012     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (169)

1. Hinuma Y, Nagata K. Hanaoka M. Nakai M, Matsumoto T, Kinoshita Kl, Shirakawa S, Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sei USA 1981;78(10):6476-80.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA. Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sei USA 1980;77:7415-9.
3. Robert-Guroff M, Nakao Y, Notake K, Ito Y, Sliski A. Gallo RC. Natural antibodies to human retrovirus HTLV in a cluster of Japanese patients with adult T cell leukemia. Science 1982;215(4535):975-8.
4. Yoshida M, Seiki M. Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sei USA 1984;8l(8):2534-7.
5. Kondo T. Nonaka H, Miyamoto N. Yoshida R. Matsue Y, Ohguchi Y, Inouye H, Komoda H, Hinuma Y, Hanaoka M. Incidence of adult Tcell leukemia-lymphoma and its familial clustering. Int J Cancer 1985;35(6):749-51.
6. Tajima K, Tominaga S, Suchi T. Kawagoe T, Komoda H, Hinuma Y, Oda T, Fujita K. Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: possible horizontal transmission of adult T-cell leukemia virus. Gann 1982:73:893-901.
7. Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, Campbell M, Goedert JJ. Blatlner WA. Modelling the risk of adult Tcell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989;43(2):250-3.
8. Kimata JT. Wong FH, Wang JJ, Ratner L. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology 1994;204(2):656-64.
9. Hahn B, Gallo RC. Franchini G, Popovic M, Aoki T, Salahuddin SZ, Markham PD, Staal LW. Clonal selection of human T-cell leukemia virus-infected cells in vivo and in vitro. Mol Biol Med 1984;2( 1 ):29-36.
10. Kimata JT, Ratner L. Temporal regulation of viral and cellular gene expression during human T-lympholropic virus type I-mcdiated lymphocyte immortalization. J Virol 1991:65(8):439X-407.
11. Franchini G. Molecular mechanisms of human T-cell leukemia lymphotropic virus type 1 infection. Blood 1995:86:3619-39.
12. Xu X. Heidenrich O. Nerenbcrg MI. HAM/TSP and ATL: Persistent paradoxes and new hypotheses. J NeuroVirol. In press.
13. Gitlin SD, Ditmer J, Reid RL, Brady JN. The molecular biology of human T cell leukemia viruses. In: Cullen B, ed. Frontiers in Molecular Biology, Oxford: University Press, 1993:159-92.
14. Seiki M, Eddy R, Shows TB, Yoshida M. Nonspecific integration of the HTLV provirus genome into adult T-cell leukemia cells. Nature 1984;309:640-2.
15. Seiki M, Hattori S, Hirayama Y, Yoshida M. Human T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemic cell DNA. Proc Natl Acad Sei USA 1983:80:3618-22.
16. Cann AJ, Rosenblatt JD, Wachsman W, Shah NP, Chen IS. Identification of the gene responsible for human T-cell leukemia virus transcriptional regulation. Nature 1985;318:571-4.
17. Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F, Pavlakis GN. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 1985;229:675-9.
18. Kiyokawa T, Seiki M, Iwashita S, Imagawa K, Shimizu F, Yoshida M. p27x-iii and p21x-iii, proteins encoded by the pX sequence of human T-cell leukemia virus type 1. Proc Natl Acad Sei USA 1985:82:8359-63.
19. Hidaka M, Inoue J, Yoshida M, Seiki M. Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J 1988;7:519-23
20. Furukawa K, Furukawa K, Shiku H. Alternatively spliced mRNA of the pX region of human T-lymphotropic virus type 1 proviral genome. FEES Lett 1991;295:141-5.
21. Koralnik U, Füllen J, Franchini G. The p 121, pi311 and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol 1993;67:2360-6.
22. Kanamori H, Suzuki N, Siomi H, Nosaka T, Sato A, Sabe H, Hatanaka M. Honjo T. HTLV-1 p27rex stabilizes human interleukin 2 receptor a chain mRNA. EMBO J 1990:9:4161-6.
23. Franchini G, Mulloy JC, Koralnik U, Lo Monico A, Sparkowski JJ, Andresson T, Goldstein DJ, Schlegel R. The human T-cell leukemia/lymphotropic virus type 1 pi21 protein cooperates with the E5 oncoprotein and binds the 16-kilodalton subunit of the vacuolar H+ ATPase. J Virol 1993;67:7701-4.
24. Pozzatti R, Vogel J, Jay G. The human T-lymphotropic virus type I Tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol Cell Biol 1990; 10(1):413-7.
25. Tanaka A, Takahashi C. Yamaoka S. Nosaka T, Maki M, Hatanaka M. Oncogenic transformation by the Tax gene of human T-cell leukemia virus type I in vitro. Proc Natl Acad Sei USA 1990;87(3):1071-5.
26. Nerenberg MI. An HTLV-I transgenic mouse model: role of the Tax gene in pathogenesis in multiple organ systems. Curr Top Microbiol Immunol 1990; 160(121): 121-8.
27. Nerenberg M, Hinrichs SH, Reynolds RK, Khoury G, Jay G. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 1987;237:1324-9.
28. Brown DA, Xu X, Kitajima I, Shinohara T, Bilakovics J, Shiner T. Nerenberg MI. Genomic footprinting of the HTLV-I LTR in a transgenic mouse tumorigenic model. Transgenics 1994; 1:377-93.
29. Nerenberg MI, Minor T, Price J, Ernst DN, Shinohara T, Schwarz H. Transgenic thymocytes are refractory to transformation by the human T-cell leukemia virus type 1 Tax gene. J Virol 1991:65:3349-53.
30. Benvenisty N, Ornitz DM, Bennett GL, Sahagan BG, Kuo A, Cardiff RD, Leder P. Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/Tax genes. Oncogene 1992:7(12):2399-405.
31. Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ, Ratner L, Development of leukemia in mice transgenic for the Tax gene of HTLV-I. Proc Natl Acad Sei USA 1995:92:1057.
32. Goh WC, Sodroski J, Rosen C, Essex M, Haseltine WA. Subcellular localization of the product of the long open reading frame of human T-cell leukemia virus type I. Science 1985;227(4691):1227-8.
33. Slamon DJ, Shimotohno K, Cline MJ, Golde DW, Chen IS. Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-1 and HTLV-II. Science 1984;226(4670):61-5.
34. Gitlin SD, Bosselut R, Gegonne A, Ghysdael J, Brady JN. Sequence-specific interaction of the Etsl protein with the long terminal repeat of the human T-lymphotropic virus type I. J Virol 1991;65(10):5513-23.
35. Smith MR, Greene WC. Characterization of a novel nuclear localization signal in the HTLV-I Tax transactivator protein. Virology 1992;187:316-20.
36. Fujii M, Tsuchiya H, Seiki M. HTLV-I Tax has distinct but overlapping domains for transcriptional activation and for enhancer specificity. Oncogene 1991;6(12):2349-52.
37. Semmes OJ, Jeang KT. Mutational analysis of human T-cell leukemia virus type I Tax: regions necessary for function determined with 47 mutant proteins. J Virol 1992;66(12):7183-92.
38. Fujisawa J, Seiki M, Sato M, Yoshida M. A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 chi HTLV-I. EMBO J 1986;5(4):713-8.
39. Sodroski J, Rosen C, Goh WC, Haseltine W. A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus. Science 1985;228:1430-4.
40. Maruyama M, Shibuya H, Harada H, Hatakeyama M, Seiki M, Fujita T, Inoue J, Yoshida M, Taniguchi T. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-I-encoded p40x and T3/Ti complex triggering. Cell 1987;48(2):343-50.
41. Siekevitz M, Feinberg MB, Holbrook N, Wong-Staal F, Greene WC. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Proc Natl Acad Sei USA 1987:84:5389-93.
42. Miyatake S, Seiki M, Yoshida M, Arai K. T-cell activation signals and human T-cell leukemia virus type I-encoded p40x protein activate the mouse granulocyte-macrophage colony-stimulating factor gene through a common DNA element. Mol Cell Biol 1988;8(12):5581-7.
43. Miyatake S, Seiki M, Malefijt RD, Heike T, Fujisawa J, Takebe Y, Nishida J, Shlomai J, Yokota T, Yoshida M, Arai, K, Arai N. Activation of T cell-derived lymphokine genes in T cells and fibroblasts: effects of human T cell leukemia virus type I p40x protein and bovine papilloma virus encoded E2 protein. Nucleic Acids Res 1988;16:6547-66.
44. Fujii M, Sassone-Corsi P, Verma IM. c-fos promoter trans-activation by the Taxi protein of human T-cell leukemia virus type I. Proc Natl Acad Sei USA 1988;85:8526-30.
45. Nagata K, Ohtani K, Nakamura M, Sugamura K. Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40Tax protein in the human T-cell line, Jurkat. J Virol 1989;63(8):3220-6.
46. Ratner L. Regulation of expression of the c-sis proto-oncogene. Nucleic Acids Res 1989;17(11):4101-15.
47. Kirn SJ, Kehrl JH, Burton J, Tendier CL, Jeang KT, Danielpour D, Thevenin C, Kim KY, Sporn MB, Roberts AB. Transactivation of the transforming growth factor beta 1 (TGF-beta 1 ) gene by human T lymphotropic virus type 1 Tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia. J Exp Med 1990;172(l):121-9.
48. Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type l.EMBOJ 1986;5(11):2883-8.
49. Lilienbaum A, Due Dodon M, Alexandre C, Gazzolo L, Paulin D. Effect of human T-cell leukemia virus type I Tax protein on activation of the human vimentin gene. J Virol 1990;64:256-263.
50. Jeang KT, Widen SG, Semmes OJ, IV, Wilson SH, Semmes, OJ. HTLV-I trans-activtor protein, Tax, is a trans-repressor of the human beta-polymerase gene. Science 1990;247:1082-4.
51. Uittenbogaard MN, Armstrong AP, Chiaramello A, Nyborg JK. Human T cell leukemia type I Tax protein represses gene expression through the basic helix-loop-helix family of transcription factors. J Biol Chem 1994;269(36)22466-9.
52. Zhao LJ, Giam CZ. Human T-cell lymphotropic virus type 1 (HTLV-I) transcriptional activator, Tax, enhances CREB binding to the HTLV-I 21-base-pair repeats by protein-protein interaction. Proc Natl Acad Sei USA 1992;89:7070-4.
53. Wagner S, Green MR. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 1993;262:395-9.
54. Baranger AM, Palmer CR, Hamm MK, Giebler HA, Brauweiler A, Nyborg JK, Schepartz A. Mechanism of DNA-binding enhancement by the human T cell leukaemia virus transactivator Tax. Nature 1995;376:606-8.
55. Perini G, Wagner S, Green MR. Recognition of bZIP proteins by the human T-cell leukemia virus transactivator Tax. Nature 1995;376:602-5.
56. Franklin AA, Kubik MF, Uittenbogaard MN, Brauweiler A, Utaisincharoen P, Matthews MA, Dynan WS, Hoeffler JP, Nyborg JK. Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF2) response and cAMP element-binding protein (CREB). J Biol Chem 1993:268:21225-31.
57. Armstrong AP, Franklin AA, Uittenbogaard MN, Giebler HA, Nyborg JK. Pleiotropic effect of the human T-cell leukemia virus Tax protein on the DNA binding activity of eukaryotic transcription factors Proc Natl Acad Sei USA 1993:90:7303-7.
58. Uittenbogaard MN, Giebler HA, Reisman D, Nyborg JK. Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein. J Biol Chem 1995;270(48):28503-6.
59. Caron C, Rousset R, Beraud C, Moncollin V, Egly JM, Jalinot P. Functional and biochemical interaction of the HTLV-I Tax 1 transactivator with TBP. EMBO J 1993; 12(11):4269-78.
60. Hirai H, Suzuki T, Fujisawa JI, Inoue JI, Yoshida M. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor KB and induces nuclear translocation of transcription factor NF-KB proteins for transcriptional activation. Proc Natl Acad Sei USA 1994:91:3584-8.
61. Suzuki T, Hirai H, Murakami T, Yoshida M. Tax protein of HTLV-I destabilizes the complexes of NF-KB and lKB-a and induces nuclear translocation of NF-KB for transcriptional activation. Oncogene 1995:10:1199-207.
62. Hirai H, Fujisawa J, Suzuki T, Ueda K, Muramatsu M, Tsuboi A, Arai N, Yoshida M. Transcriptional activator Tax of HTLV-I binds to the NF-kappa B precursor p!05. Oncogene 1992;7(9): 1737-42.
63. Suzuki T, Hirai H, Fujisawa J, Fujita T, Yoshida M. A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-kappa B p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-kappa B site and CArG box. Oncogene 1993;8(9):2391-7.
64. Pepin N, Roulston A, Lacoste J, Lin R, Hiscott J. Subcellular redistribution of HTLV-I Tax protein by NF-KB/Rel transcription factors. Virology 1994;204(2):706-16.
65. Suzuki T, Hirai H, Yoshida M. Tax protein of HTLV-I interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription. Oncogene 1994;9(11):3099-105.
66. Kanno T, Brown K, Siebenlist U. Evidence in support of a role for human T-cell leukemia virus type I Tax in activating NF-kappa B via stimulation of signaling pathways. J Biol Chem 1995:270(20): 11745-8.
67. Lacoste J, Petropoulos L, Pepin N, Hiscott J. Constitutive phosphorylation and turnover of IKB a in human T-cell leukemia virus type Iinfected and Tax-expressing T cells. J Virol 1995;69(l):564-9.
68. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-KB activation. Mol Cell Biol 1995;15(5):2809-18.
69. Finco TS, Beg AA, Baldwin AS, Jr. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc Natl Acad Sei USA 1994:91:11884-8.
70. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa B l precursor protein and the activation of NF-kappa B. Cell 1994;78(5):773-85.
71. Maggirwar SB, Harhaj E, Sun SC. Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor. Oncogene 1995:11(5):993-8.
72. Sun SC, Elwood J, Beraud C, Greene WC. Human T-cell leukemia virus type I Tax activation of NF-KB/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p67)-mediated induction of the c-rel gene. Mol Cell Biol 1994; 14( 1 I ):7377-84.
73. Adya N, Giam CZ. Distinct regions in human T-cell lymphotropic virus type I Tax mediate interactions with activator protein CREB and basal transcription factors. J Virol I995;69(3):1834-41.
74. Grassmann R, Berchtold S, Radant I, Alt M, Fleckenstein B, Sodroski JG, Haseltine WA, Ramstedt U. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J Virol 1992;66(7):457()-5.
75. Rosin 0, Koch C, Radant I, Semmes O, Jeang KT, Grassman R. The capacity of HTLV-I Tax to induce NF-xB activity is not required for T-cell immortalization [abstract]. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:215.
76. Richardson JH, Zani C, Sodroski JG, Waldmann TA, Marasco WA. Growth suppression of HTLV-I infected transformed human lymphocytes by cocultivation [abstract]. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:246.
77. Kitajima I, Shinohara T, Bilakovics J, Brown DA, Xu X, Nerenberg M. Ablation of transplanted HTLV-I Tax transformed tumors in mice by antisense inhibition of NF-xB [published erratum appears in Science 1993;259:1523 (letter)]. Science 1992;258:1792-5.
78. Popovic M, Lange-Wantzin G, Sarin PS, Mann D, Gallo RC. Transformation of human umbilical cord blood cells by human T-cell leukemia/lymphoma virus. Proc Natl Acad Sei USA 1983:80:5402-6.
79. Markham PD, Salahuddin SZ, Kalyanaraman VS, Popovic M, Sarin P, Gallo RC. Infection and transformation of fresh human umbilical cord blood cells by multiple sources of human T-cell leukemia-lymphoma virus (HTLV). IntJCancer 1983:31:413-20.
80. Schwartz, RH. A cell culture model for T lymphocyte clonal anergy. Science 1990:248:1349-56.
81. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1994:76:263-74.
82. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4 and B7/BB1 in interleukin-2 production and immunotherapy, Cell 1992;71:1065-8.
83. June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T-cell activation. Immunol Today 1990;! 1:211-6.
84. Janeway CA, Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994:76:275-85.
85. Crabtree GR. Contingent genetic regulatory events in T lymphocyte activation. Science 1989:243:355-61.
86. Gazzolo L, Doc Dodon M. Direct activation of resting T lymphocytes by human T-lymphotropic virus type 1. Nature 1987;326:714-7.
87. Wucherpfennig KW. Hollsberg P, Richardson JH, Benjamin D. Hafler DA. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. Proc Natl Acad Sei USA 1992:88:2110-4.
88. Valle A, Garrone P. Yssel H, Bonnel'oy JY, Freedman AS, Freeman G, Nadler LM, Banchereau J. mAB 104. a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-I-transformed T cells. Immunology 1990:69:531-5.
89. Chlichlia K, Moldenhauer G, Daniel PT, Busslinger M, Gazzolo L, Schirrmacher V, Khazaie K. Immediate effects of reversible HTLV-I Tax function: T-cell activation and apoptosis. Oncogene 1995:10:26977.
90. McGuire KL, Curtiss VE, Larson EL, Haseltine WA. Influence of human T-cell leukemia virus type I Tax and rex on interleukin-2 gene expression. J Viro! 1993:67:1590-9.
91. Cohen JJ, Duke RC. Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992:10:267-93.
92. Kawabe Y, Ochi A. Programmed cell death and extrathymic reduction of VB8+CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 1991:349:245-8.
93. Leno M, Simpson RM, Bowers FS, Kindt TJ. Human T lymphocyte virus 1 from a leukemogenic cell line mediates in vivo and in vitro lymphocyte apoptosis. J Exp Med 1995:181:1575-80.
94. Zhao TM, Robinson MA, Sawasdikosol S, Simpson RM, Kindt TJ. Variation in HTLV-1 sequences from rabbit cell lines with diverse in vivo effects. Virology 1993:195:271-4.
95. Zhao TM, Robinson MA, Bowers FS. Kindt TJ. Characterization of an infectious molecular clone of human T-cell leukemia virus type 1. J Virol 1995:69:2024-30.
96. Copeland KF, Haaksma AG. Goudsmit J, Krammer PH. Heeney JL. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type 1 Tax. AIDS Res Hum Retroviruses 1994; 10:1259-68.
97. Fujita M. Shiku H. Differences in sensitivity to induction of apoptosis among rat fibroblast cells transformed by HTLV-I Tax gene or cellular nuclear oncogenes. Oncogene 1995; 11:15-20.
98. Schwartz-Comil, I, LeRhun D, Laine V, Oswaki I, DaCosta B, Willems L. Levy D. BLV-Tax confers resistance to cell death signals involved in the control of lymphoid cell population density [abstract]. J Acquir Immune Defic Syndr Hum Retrovirol 1995:10:220.
99. Sakashita A, Hattori T, Miller CW, Suzushima H, Asou N, Takatsuki K, Koeffler HP. Mutations of the p53 gene in adult T-cell leukemia. Blood 1992;79(2):477-80.
100. Lubbert M, Miller CW, Kahan J, Koeffler HP. Expression, methylation and chromatin structure of the p53 gene in untransformed and human T-cell leukemia virus type I-transformed human T-lymphocytes. Oncogene 1989;4(5):643-51.
101. Reid RL, Lindholm PF, Mireskandari A, Dittmer J, Brady JN. Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I. Oncogene 1993:8(11):3029-36.
102. Oltvai ZN, Milliman CL, Korsmeyer, SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993:74:609-19.
103. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993:74:597-608.
104. Veis DJ, Sentman CL, Bach EA, Korsmeyer SJ. Expression of the bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J Immunol 1993:151:2546-54.
105. Merino RL, Ding L, Veis DJ, Korsmeyer SJ, Nunez G. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J 1994;13:683-91.
106. Broome HE, Dargan CM, Krajewski S, Reed JC. Expression of Bcl-2, Bcl-x and Bax after T cell activation and IL-2 withdrawal. J Immunol 1995:155:2311-7.
107. Yamada T, Yamaoka S, Goto T, Nakai M, Tsujimoto Y, Hatanaka M. The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein. J Virol 1994;68(5):3374-9.
108. Xu X, Kang SH, Heidenreich O, Okerholm M, O'Shea JJ, Nerenberg MI. Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus (HTLV-I) Tax protein or virus-transformed cells. J Clin Invest 1995;96:1548-55.
109. Migone TS, Lin JX, Cereseto A, Mulloy JC, O'Shea JJ, Franchini G, Leonard WJ. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science 1995;269:79-81.
110. Rane SG, Reddy EP. JAK3: A novel kinase associated with terminal differentiation of hematopoietic cells. Oncogene 1994:9:2415-23.
111. Kawamura M, McVicar DW, Johnston JA, Blake TB, Chen YQ. Lal BK, Lloyd AR, Kelvin DJ, Staples JE, Ortaldo JR, O'Shea JJ. Molecular cloning of L-Jak, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sei USA 1994:91:6374-8.
112. Johnston JA, Kawamura M, Kirken RA, Chen YQ, Blake TB, Shibuya K, Ortaldo JR, McVicar DW, O'Shea JJ. Phosphorylation and activation of the Jak3 Janus kinase in response to interleukin-2. Nature 1994:370:151-3.
113. Fujii H, Nakagawa Y, Schindler U, Kawahara A, Mori H, Gouilleux F, Groner B, Ihle JN, Minami Y, Miyazaki T, Taniguchi, T. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. Proc Natl Acad Sei USA 1995;92(12):5482-6.
114. Brunn GJ, Falls EL, Nilson AE, Abraham RT, Protein-tyrosine kinase-dependent activation of STAT transcription factors in interleukin2- or inlerleukin-4-stimulatcd T lymphocytes. J Biol Chem 1995:270(19): 11628-35.
115. Malabarba MG, Kirken RA, Rui H, Koettnitz K, Kawamura M, O'Shea JJ. Kalthoff FS, Farrar WL. Activation of JAK3, but not JAK I, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha. J Biol Chem 1995;270(16):9630-7.
116. Howard OM, Kirken RA, Garcia GO, Hackett RH, Farrar WL. Structural domains of interleukin-2 receptor beta critical for signal transduction: kinase association and nuclear complex-formation. Biochem J 1995;306(Pt l):217-24.
117. Miyazaki T, Kawahara A, Fujii H, Nakagawa Y, Minami Y, Liu ZJ, Oishi I, Silvennoinen O, Witthuhn BA, Ihle JN, Taniguchi, T. Functional activation of Jak 1 and Jak3 by selective association with IL-2 receptor subunits. Science 1994;266(5187):1045-7.
118. Russell SM, Johnston JA, Noguchi M, Kawamura M, Bacon CM, Friedmann M, Berg M, McVicar DW, Witthuhn BA, Silvennoinen O, Goldman AS, Schmalstieg FC, Ihle JN, O'Shea, JJ, Leonard WJ. Interaction of IL-2R beta and gamma c chains with Jak l and Jak3: implications for XSCID and XCID. Science 1994;266(5187):1042-5.
119. Boussiotis VA, Barber DL, Nakarai T, Freeman GJ. Gribben JG, Bernstein GM, D'Andréa AD, Ritz J, Nadler LM. Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science 1994;266(5187): 1039-42.
120. Sharfe N, Dadi HK, Roifman CM. JAK3 protein tyrosine kinase mediates interleukin-7-induced activation of phosphatidylinositol-3' kinase. Blood 1995;86(6):2077-85.
121. Yin T, Keller SR, Quelle FW, Witthuhn BA, Tsang ML, Lienhard GE, Ihle JN, Yang YC. Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases J BiolChem 1995;270(35):20497-502.
122. Keegan AD, Johnston JA, Tortolani PJ, McReynolds LJ, Kinzer C, O'Shea JJ, Paul WE. Similarities and differences in signal transduction by interleukin 4 and interleukin 13: analysis of Janus kinase activation. Proc Natl Acad Sei USA 1995;92(17):7681-5.
123. Fenghao X, Saxon A, Nguyen A, Ke Z, Diaz-Sanchez D, Nel A. Interleukin 4 activates a signal transducer and activator of transcription (Stat) protein which interacts with an interferon-gamma activation sitelike sequence upstream of the I epsilon exon in a human B cell line. Evidence for the involvement of Janus kinase 3 and interleukin-4 Stat. J Clin Invest I995;96(2):907-14.
124. Yin T, Yang L, Yang YC. Tyrosine phosphorylation and activation of JAK family tyrosine kinases by interleukin-9 in MO7E cells. Blood 1995;85(11):3101-6.
125. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Aldieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994;264(5161):965-8.
126. Asao H, Tanaka N, Ishii N, Higuchi M, Takeshita T, Nakamura M, Shirasawa T, Sugamura K. Interleukin 2-induced activation of JAK3: possible involvement in signal transduction for c-myc induction and cell proliferation. FEES Lett 1994:351(2):201-6.
127. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O. Signaling by the cytokine receptor superfamily: JAKs and STATs. TIBS 1994; 19:222-7.
128. Harrison DA, Binari R, Nahreini TS, Gilman M, Perrimon N. Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J 1995; 14:2857-65.
129. Kitajima I, Shinohara T, Minor T, Bibbs L, Bilakovics J, Nerenberg MI. Human T-cell leukemia virus type I Tax transformation is associated with increased uptake of oligodeoxynucleotides in vitro and in vivo. J Biol Chem 1992;267(36):25881-8.
130. Peebles RS, Maliszewski CR, Sato TA, Hanley-Hyde J, Maroulakou IG, Hunziker R, Schneck JP, Green JE. Abnormal B-cell function in HTLV-I-Tax transgenic mice. Oncogene 1995;10(6):104551.
131. Umehara F, Nakamura A, Izumo S, Kubota R, Ijichi S. Kashio N, Hashimoto K, Usuku K, Sato E, Osame M. Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: a possible mechanism to control viral infection in the central nervous system. J Neuropathol Exp Neurol 1994;53:617-24.
132. Seto K, Abe M, Ohya O, Itakura O, Ishiguro N, Ikeda H, Wakisaka A, Yoshiki T. A rat model of HTLV-I infection: development of chronic progressive myeloneuropathy in seropositive WKAH rats and related apoptosis. Acta Neuropathol 1995;89:483-90.
133. Dendorfer U, Oettgen P, Libermann TA. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol 1994; 14:4443-54.
134. Wang XY, Fuhrer DK, Marshall MS, Yang YC. Interleukin-11 induces complex formation of Grb2, Fyn, and Jak2 in 3T3L1 cells. J Biol Chem 1995;270:27999-8002.
135. Wen Z, Zhong Z, Darnell JE, Jr. Maximal activation of transcription by Stall and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995;82:241-50.
136. Matsumoto K, Akashi K, Shibata H, Yutsudo M, Hakura A. Single amino acid substitution (58Pro>Ser) in HTLV-I Tax results in loss of ras cooperative focus formation in rat embyro fibroblasts. Virology 1994:200:813-5.
137. Cobb MH, Goldsmith EJ. How MAP kinases are regulated, [review]. J Biol Chem 1995;270:14843-6.
138. Blenis J. Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sei USA 1993;90:5889-92.
139. Schlessinger J. SH2/SH3 signaling proteins. Curr Opin Genet Dev 1994:4:25-30.
140. Winitz S, Russell M, Qian NX, Gardner A, Dwyer L, Johnson GL. Involvement of ras and raf in the Gi-coupled acetylcholine muscarinic m2 receptor activation of mitogen-activated protein (MAP) kinase kinase and MAP kinase. J Biol Chem 1993;268:19196-9.
141. Howe LR, Marshall CJ. Lysophosphatidic acid stimulates mitogen-activated protein kinase activation via a G-protein-coupled pathway requiring p21ras and p74raf-l. J Biol Chem 1993:268:20717-20.
142. Rayter SI, Woodrow M, Lucas SC, Cantrell DA, Downward J. p21ras mediates control of IL-2 gene promoter function in T cell activation. EMBO J 1992;ll(12):4549-56.
143. Leevers SJ, Marshall CJ. Activation of extracellular signal-regulated kinase, ERK2, by p21 ras oncoprotein. EMBO J 1992; 11:569-74.
144. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis JM, Jon LI. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 1994:372:794-8.
145. Yan M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR, Templeton DJ. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 1994;372:798-800.
146. Minden A, Lin A, McMahon M, Lange-Carter C, Derijard B, Davis RJ, Johnson GL, Karin M. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 1994:266:1719-23.
147. Lange-Carter ÇA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 1993;260:315-9.
148. Derijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ, Davis RJ. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms [published erratum appears in Science 1995; 269:17]. Science 1995;267:682-5.
149. SIuss HK, Barrett T, Derijard B, Davis RJ. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 1994:14:8376-84.
150. Ahn NG, Seger R, Bratlien RL, Krebs EG. Growth factor-stimulated phosphorylation cascades: activation of grwoth factor-stimulated MAP kinase. Ciba Found Symp 1992; 164:113-26.
151. Magnuson NS, Beck T, Vahidi H, Hahn H, Smola U, Rapp UR. The Raf-1 serine/threonine protein kinase. Semin Cancer Biol 1994;5(4):247-53.
152. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994;369:156-60.
153. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994:76:1025-37.
154. Galcheva-Gargova Z, Derijard B, Wu IH, Davis RJ. An osmosensing signal transduction pathway in mammalian cells. Science 1994;265:806-8.
155. Han J, Lee JD, Bibbs L, Ulevtich RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994;265(5173):808-11.
156. Raingeaud J, Gupta S, Rogers JS. Dickens M, Han J, Ulevitch RJ, Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 1995:270:7420-6.
157. Cowley S, Paterson H, Kemp P. Marshall CJ. Activation of MAP kinase kinase is necessary and sufficient for PC 12 differentiation and for transformation of NIH 3T3 cells. Cell 1994:77:841-52.
158. Brunei A, Pages G, Pouyssegur J. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene 1994:9:3379-87.
159. Xia Z, Dickens M, Raingeaud J, Davis RJ. Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995:270:1326-31.
160. Westwick JK, Weitzel C, Leffert HL, Brenner DA. Activation of Jun kinase is an early event in hepatic regeneration. J Clin Invest 1995:95:803-10.
161. Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben-Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994;77:727-36.
162. Raitano AB, Hambuch T, Sawyers C. BCR-ABL activates Jun kinase and requires for transformation [abstract]. Eleventh Annual Meeting on Oncogenes 1995:6.
163. Benn J, Schneider RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sei USA 1994:91:10350-4.
164. Sontag E. Fedorov S, Kamibayashi C, Robbins D, Cobb M, Mumby M. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the Map kinase pathway and induces cell proliferation. Cell 1993:75:887-97.
165. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature 1991 ;353:670-4.
166. Hibi M. Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 1993:7:2135-48.
167. Kallunki T, Su B, Tsigelny I, Sluss HK, Derijard B, Moore G, Davis R, Karin M. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 1994;8:2996-30()7.
168. Gupta S, Campbell D, Derijard B, Davis RJ. Transcription factor ATF2 regulation by the JNK signal transduction. Science 1995:267:389-93.
169. Xu X, Brown DA, Kitajima I, Bilakovics J, Fey LW, Nerenberg MI. Transcriptional suppression of the HTLV-I LTR occurs by an unconventional interaction of a CREB with the R region. Mol Cell Biol 1994:14:5371-83.